Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia.

计划入组 123 人 · 首次发布于 2014 年 4 月 8 日

ZS Ph2/3 Dose-response Study in Japan

计划入组 103 人 · 首次发布于 2017 年 4 月 25 日

A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS)

计划入组 22 人 · 首次发布于 2017 年 9 月 14 日

ZS-802

ZS-07

ZS-03

ZS PHARMA INC

United States

ZS PHARMA, INC.

United States

Bioprojet Pharma

Belgium

NICE Expands NHS Funding for AstraZeneca's Lokelma to Include Outpatient Care

Ovid Therapeutics Reshapes Executive Leadership to Drive Next Phase of CNS Pipeline Development

Rivus Pharmaceuticals Strengthens Leadership Team Ahead of Critical Phase 2b MASH Trial Results